Study period | ||||
---|---|---|---|---|
Characteristic | Baseline n = 71 | Postintervention n = 66 | pvalue | |
Birthweight, g, mean (SD) | 3494 (489) | 3369 (451) | 0.23 | |
Gestational age, weeks, mean (SD) | 39.5 (1.1) | 39.7 (1.3) | 0.14 | |
Cesarean delivery | 25 (35.2%) | 26 (39.4%) | 0.34 | |
Apgar, 5 min | ||||
0–3 | 0 (0%) | 2 (3%) | 0.01 | |
4–6 | 6 (8.5%) | 15 (22.7%) | ||
7–10 | 65 (91.6%) | 49 (74.2%) | ||
GBS status | ||||
Positive | 15 (21%) | 18 (27.3%) | 0.57 | |
Negative | 50 (70.4%) | 45 (68.2%) | ||
Unknown | 6 (8.5%) | 3 (4.5%) | ||
Maternal temperature > 38ºC | 30 (42.3%) | 28 (42.4%) | 0.98 | |
ROM > 18 h | 21 (29.6%) | 13 (19.7%) | 0.18 | |
Intrapartum antibiotic therapy | 38 (53.5%) | 45 (68.2%) | 0.08 | |
CRP, mg/dL | ||||
Onset, median (IQR) | 0.6 (0.1–2.2) | 1.41 (0.04–3.60) | 0.39 | |
Highest, median (IQR) | 3.7 (2.9–6.7) | 3.5 (1.8–5.7) | 0.09 |